Ads
-
Related paper
- Use of Novel oral anticoagulants (NOACs) in patients with risk of stroke in non valvular Atrial Fibrillation (AF)
- ROLE OF NOVEL ORAL ANTICOAGULANTS (NOACS)IN PATIENTS WITH ATRIAL FIBRILLATION CARDIOVERSION- AN EXECUTIVE
- ROLE OF NOVEL ORAL ANTICOAGULANTS (NOACS)IN PATIENTS WITH ATRIAL FIBRILLATION CARDIOVERSION- AN EXECUTIVE SUMMARY
- New Oral Anticoagulants in the Treatment of Patients with Atrial Fibrillation
- CLINICAL AND PROGNOSTIC SIGNIFICANCE OF OBSTRUCTIVE SLEEP APNEA/HYPOPNEA IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
- CLINICAL CHARACTERISTICS OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND CONCOMINANT OBSTRUCTIVE SLEEP APNOEA/HYPOPNOEA
- Effect of electrocautery maze procedure and amiodarone in rheumatic valvular heart disease patients with atrial fibrillation undergoing mitral valve replacement surgery
- PREDICTION OF ATRIAL FIBRILLATION RECURRENCE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION SUFFERING FROM OBSTRUCTIVE SLEEP APNOEA/HYPOPNOEA SYNDROME
- Different Role of Left Atrial Size and Function in Patients with Paroxysmal versus Persistent Atrial Fibrillation. Wellnhofer: LA Size & Function in Atrial Fibrillation
- The Cumulative Incidence of Stroke, Myocardial Infarction, Heart Failure and Sudden Cardiac Death in Patients with Atrial Fibrillation